Approval · Notice of Compliance 38405 · 2026
VOXZOGO: Notice of Compliance 38405
Issued October 2, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 38405
- Date
- October 2, 2026
- Company
- Biomarin International LimitedRingaskiddy, Cork, Ireland
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updates to the Product Monograph
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VOXZOGO | Not yet assigned | — |
Medicinal ingredients
- VOSORITIDE 0.4 MG per VIAL
- VOSORITIDE 0.56 MG per VIAL
- VOSORITIDE 1.2 MG per VIAL